Journal of the Korean Society of Food Science and Nutrition (한국식품영양과학회지)

The Korean Society of Food Science and Nutrition (한국식품영양과학회)
권호 표지
DOI QR코드

DOI QR Code

Inhibitory Mechanism of Blood Coagulation and in vivo Anticoagulant Activities of Polysaccharides Isolated from Codium fragile

청각으로부터 분리한 다당류의 혈액응고 저해기작 및 in vivo 항응고 활성

  • Shim, Yun-Yong (Graduate School of Biotechnology, Korea University) ;
  • An, Jeung-Hee (Graduate School of Biotechnology, Korea University) ;
  • Cho, Won-Dai (Agricultural Cooperative College) ;
  • Chun, Hyug (Graduate School of Biotechnology, Korea University) ;
  • Kim, Kyung-Im (Graduate School of Biotechnology, Korea University) ;
  • Cho, Hong-You (Graduate School of Biotechnology, Korea University) ;
  • Yang, Han-Chul (Graduate School of Biotechnology, Korea University)
  • Published : 2002.10.01
Download PDF
⟨ Previous Next ⟩

Abstract

Inhibitory mechanism of the anticoagulant polysaccharide purified from Codium fragile was investigated. The anticoagulant compounds (Cf-30-IV-4-ii, CF-30-IV) prolonged the clotting time at both activated partial thrombo-plastin time (aPTT) and thrombin time (TT). The Inhibition factor assay of instrinsic coagulation pathway in the blood showed that the anticoagulant polysaccharide (CF-30-IV-4-ii) inhibited other factors such as Ⅷ, Ⅸ, Ⅵ and Ⅷ of the coagulation cascade, which did not affect the lupus anticoagulant AB activity. In the thrombin inhibition pattern the CF-30-IV-4-ii did not directly influence the fibrine formation mediated by thrombin but af-fected the anticoagulant activity through the activation of antithrombin III. Base on these result, the anticoaglant polysaccharide (CF-30-IV-4-ii) was considered to inhibit serine pretense involved in the blood coagulation cascade through the enhancing antithrombin III activity. The residual effects of anticoagulant activity and antithrombosis were tested with ICR mice. The anticoagulant polysaccharide (CF-30-W) kept its anticoagulant activitv for 6 hrs with 100% survival at a dose of 150 mg/kg in the antithromboisis test. The anticoagulant effect of CF-30-RF in ex vivo was proportional to the concentration of intravenously injected dose up to 100 mg/kg.

청각에서 분리된 항응고 다당류의 혈액응고 저해기작을 검토하였다. 항응고성 다당 획분(CF-30 IV-ii, CF-30-IV)은 내인성 경로와 공통 경로에서 농도 의존적으로 작용한다. 항응고획분(CF -30-IV-ii)은 내인성 경로의 factor asaay시 lupus an ticoagulant 항체의 활성 에 영 향을 주지 않았으나 응고과정 중 factor Ⅷ, Ⅸ, \ulcorner, \ulcorner의 활성을 저해하였다. CF-30-IV-4-ii는 농도의 존적으로 fibrine을 생성시키지 않음으로써 thrombin에 직접 작용하지 않는 antithrombin m의존적 항응고 활성 기작을 보였다. 청각의 항응고 활성은factor assay와thrum bin의 저해 양식을 고려해볼 때 antithrombin III의 활성을 증대시켜 혈액응고 인자 중 serine proteinase의 활성을 저해함으로써 항응고 활성을 나타내는 물질로 판명되었다. CF-30-IV획분의 in vivo 활성을 측정한 결과 꼬리정 맥주사에 의해 150 mg/kg의 농도로 마우스에 투여시 thrombin에 대한 100%의 항치사성 효과를 나타내었다 또한 CF-30-IV를 마우스의 꼬리 정맥에 주입하고 혈액을 채취 ex vivo상에서 항응고 활성을 측정한 결과, 생체내에서 100mg1kg의 농도까지도 시료량에 의존하는 항응고 활성을 보였다

Keywords

References

  1. Richard L, Mueller MD. 1994. History of drudgs for thrombotic disease. Circulation 89: 432-450.
  2. Chen YL, Wang TC, Liang SC, Teng CM, Tzeng CC. 1996. Synthesisand evaluation of coumarin alpha-methylene-gammabutyrolactones:a new class of platelet aggregation inhibitors.Chem Pharm Bull (Tokyo) 44: 1591-1595. https://doi.org/10.1248/cpb.44.1591
  3. Jappe U, Reinhold D, Bonnekoh B. 2002. Arthus reaction to lepirudin, a new recombinant hirudin, and delayed-type hypersensitivity to several heparins and heparinoids, with tolerance to its intravenous administration. Contact Dermatitis46: 29-32. https://doi.org/10.1034/j.1600-0536.2002.460106.x
  4. Hook M, Bjork I, Hopwood J, Lingahl U. 1976. Anticoagulant activity of heparin: Separation of high activity and low activity heparin speices by affinity chromatography on immobilozed antithrombin. FEBS Letter 66: 90-93. https://doi.org/10.1016/0014-5793(76)80592-3
  5. Kenneth AB. 1995. Natural anticoagulants and prethrombolic state. In Blood. Lippincott JB Company, Philadephia. p 125.
  6. Jaques LB. 1979. Heparins: Anionic polyelectroylte drugs. Pharmacology and Experimental Therapeutics 31: 99-166.
  7. Koo JG, Jo KS, Do JR, Woo SJ. 1995. Isolation and purificationof fucoidans from Laminaria religiosa and Undaria in Korea.J Korea Fish Soc 28: 227-236.
  8. Kim JG, Seo HS, Cho HY, Yang HC. 1998. Studies on the blood anticoagulant polysacchride isolated from hot warter extracts of Hizikia fusiforme. J Korean Soc Food Sci Nutr 27: 1204-1210.
  9. Yoon JA, Yu KW, Jun WJ, Cho HY, Son YS, Yang HC. 2000.Screening of anticoagulant activity in th extracts of edible seaweeds and optimization of extraction condition. J KoreanSoc Food Sci Nutr 29: 1098-1106.
  10. Arasaki S, Arasaki T. 1983. Vegetables from the sea. Japan Pub., Tokyo. p 169-189.
  11. Jones TM, Albersheim P. 1972. A gas chromatographic method for determination of aldose and uronic acid constituent of plant cell wall polysaccharides. Plant Physiol 49: 926-936. https://doi.org/10.1104/pp.49.6.926
  12. Dodgson KS, Price RG. 1962. A note on the determination of the ester sulphate content of sulphated polysaccharides. BiochemJ 84: 106-110. https://doi.org/10.1042/bj0840106
  13. Park MK, Kweon MH, Cho HY, Yang HC. 1999. Anticoagulant activity of sulfated polysaccharides isolated from Codium fragile. J Korean Soc Agric Chem Biotechnol 42:140-146.
  14. Kiyohara H, Cyong JC, Yamada H. 1989. Relationship betweenstructure and activity of anti-complementary arabinogalactanfron the roots of Angelica acutiloba Kitagawa. CarbohydrRes 193: 193-200. https://doi.org/10.1016/0008-6215(89)85118-3
  15. Fox I, Dawson A, Loynds P, Eisner J, Findlen K, Levin E,Hanson D, Mant T, Wagner J, Maragaonre J. 1993. Anticoagulant activity of $Hirulog^{TM}$, a direct thrombin inhibitor, inhumans. Thromb Haemost 69: 157-163.
  16. Takahashi O. 2000. Characteristics of rat platelets and relative contributions of platelets and blood coagulation to haemostasis.Food Chem Toxicol 38: 203-218. https://doi.org/10.1016/S0278-6915(99)00155-6
  17. Chi CW, Liu HZ, Liu CY, Chibber BA, Castellion FJ. 1989.The inhibition of the enzymatic activity of blood coagulation and fibrinolytic serine proteases by a new leupeptin-like inhibitor, and its structural analogues, isolated from streptomyces griseus. J Antibiotics 42: 1506-1512. https://doi.org/10.7164/antibiotics.42.1506
  18. Metzig C, Grabowska E, Eckert K, Rehse K, Maurer HR.1999. Bromelain proteases reduce human platelet aggregation in vitro, adhesion to bovine endothelial cells and thrombus formation in rat vessels in vivo. In vivo 13: 7-12.
  19. Broersma RJ, Kutcher LW, Heminger EF, Krstenansky JL,Marshall FN. 1991. Antithrombotic activity of a novel C-terminal hirudin analog in experimental animals. Thromb Haemost65: 377-81.
  20. Suzki N, Kitazoto K, Takamatsu J, Saito H. 1991. Antithrombc and anticoagulant activity of depolymerized fragment of the glycosaminoglycan extracts from Stcjops japonicus Slenka. Thrombosis and Haemostasis 65: 369-373.
  21. Lee JI, Lee HS, Jun WJ, Yu KW, Shin DH, Hong BS, ChoHY, Yang HC. 2000. Anticoagulation activity pattern and in vivo test of extract from Eugenia caryophyllata. J Korean Soc Food Sci Nutr 29: 543-548.
  22. Guglielmone HA, Agnese AM, Nunez Montoya SC, CabreraJL. 2002. Anticoagulant effect and action mechanism of sulphated flavonoids from Flaveria bidentis. Thrombosis Res 105: 183-188. https://doi.org/10.1016/S0049-3848(01)00419-4
  23. Hotchkiss KA, Chesterman CN, Hogg PJ. 1994. Inhibition of heparin activity in plasma by soluble fibrin: evidence for ternary thrombin-fibrin-heparin complex formation. Blood 84:498-503.
  24. Permpikul P, Rao LV, Rapaport SI, Samnel IR. 1994. Functionaland binding studies of the roles of prothrombin and $\beta$-2-glycoprotein in the expression of lupus anticoagulant activity. Blood 83: 2878-2892.
  25. Laurence AH. 1995. Principles and practice of hematology, antiplatelet and anticoagulant therapy. In Blood. JB LippincottCompany, Philadelphia. p 56.
  26. Rogalski J, Dawidowicz AL, Wiater A, Gibula K, WiniarczykS. 1998. The preparation of specific sorbents with polyclonal antibodies as a ligand for purification of human, antithrombin III. Acta Microbiol Pol 47: 153-65.

Cited by

  1. Removal of Off-flavor from Laminaria Japonica by Treatment Process of Supercritical Carbon Dioxide vol.18, pp.2, 2012, https://doi.org/10.7464/ksct.2012.18.2.191
  2. Quality Characteristics of Sponge Cake Added with Laminaria japonia Powder vol.25, pp.4, 2012, https://doi.org/10.9799/ksfan.2012.25.4.922
  3. Characteristics of Omegisul with Seeweeds (Sargassum fulvellum and Hizikia fusiformis) and Their Qualities vol.45, pp.5, 2016, https://doi.org/10.3746/jkfn.2016.45.5.723
  4. Effects of Dietary Supplementation of Alga Mixtures (Hizikia fusiformis and Ecklonia cava) on Innate Immunity and Disease Resistance Against Edwardsiella tarda in Olive Flounder (Paralichthys olivaceus) vol.42, pp.6, 2009, https://doi.org/10.5657/kfas.2009.42.6.614
  5. Effects of Onion Peel Extracts on Blood Circulation in Male Smokers vol.39, pp.12, 2010, https://doi.org/10.3746/jkfn.2010.39.12.1790
  6. 한국산 5종 해조류의 항산화효과와 총 폴리페놀 함량과의 관련성 vol.34, pp.8, 2002, https://doi.org/10.3746/jkfn.2005.34.8.1143
  7. 패 추출물의 항산화능 및 이화학적 특성에 미치는 감마선 조사의 영향 vol.37, pp.11, 2008, https://doi.org/10.3746/jkfn.2008.37.11.1485
  8. 죽력의 in vitro에서의 angiotensin-converting enzyme 저해효과와 마우스모델에서 혈행개선효과 vol.24, pp.7, 2002, https://doi.org/10.11002/kjfp.2017.24.7.992
  9. 해조류 청각(Codium fragile) 에탄올 추출물의 항산화에 관한 연구 vol.5, pp.4, 2002, https://doi.org/10.17703/jcct.2019.5.4.467